Purchasers Can Bring Antitrust Suits in Patent Disputes, FTC and DoJ Argue
Executive Summary
The Federal Trade Commission and the Department of Justice are backing a group of direct purchasers in their antitrust suit against Ferring and Aventis
You may also be interested in...
Arbor Emphasizes Risks Of Its Own Product In Suit Against US FDA To Block Nymalize Generics
FDA concluded that original formulation of brain hemorrhage treatment was not discontinued for safety or effectiveness reasons, saying Arbor had other options to reduce risk of confusion between the new and original formulations. But the sponsor argues that withdrawal was part of FDA-approved risk mitigation plan.
CooperSurgical Lands US FDA Warning Letter Over ParaGuard TV Spot
The agency's "Bad Ad" program issued a warning letter that claims the promotion for CooperSurgical's copper-containing intrauterine contraceptive lacked any safety information.
Supreme Court May Find Patent Board Judges Unconstitutionally Appointed But Favor Narrow Fix
During oral argument in the Arthrex case, several justices seemed to agree with the Federal Circuit that PTAB judges should have been appointed by the president. They could opt to get around the problem by enabling the PTO director to review all panel decisions.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: